A Maryland drug affordability board can move forward with a plan to cap how much the state and local governments pay for ...

SAVANNAH, Georgia — A new clinical education tool aims to speed the diagnosis of amyotrophic lateral sclerosis (ALS), which ...

An interim analysis from a long-term open-label extension study has underlined the clinical efficacy and safety of ...

The Froedtert & MCW health network has been using the Xealth digital health platform, which is integrated into its EHR system ...

Novartis has lost a bid to keep a generic version of its top-selling heart failure drug Entresto off the U.S. market by ...

Not every company is jumping onto the bandwagon and investing into weight loss drugs, however. One of the largest healthcare ...

U.S. consumer groups and two large labor unions urged the U.S. Federal Trade Commission on Thursday to block Novo Holdings, ...

The Philippine Press Institute (PPI) together with Novartis held a hybrid seminar-workshop for journalists entitled “Anatomy ...

With Friday’s ruling by New Jersey District Judge Zahid Quraishi, Novartis joins a growing list of pharmaceutical companies ...

The Fortune 500 Europe has a feeble share of tech companies. But its industrial giants are increasingly turning to generative ...

Novartis is paying Chengdu Baiyu Pharmaceutical $70 million to add to its crop of cancer candidates. | Novartis is paying ...

As a host of generics circle the gates, Novartis has lost another bid to waylay MSN Pharmaceuticals’ copycat of the Swiss ...